Bloomberg News

Roche Raises Illumina Takeover Bid to $51 a Share

March 29, 2012

Tablets of Roche Holding AG's Tarceva cancer drug are arranged for a photograph. Photographer: JB Reed/Bloomberg

Tablets of Roche Holding AG's Tarceva cancer drug are arranged for a photograph. Photographer: JB Reed/Bloomberg

Roche Holding AG (ROG) raised its bid for Illumina Inc. (ILMN:US) to $51 a share. The company commented in a statement today.

To contact the editor responsible for this story: Thomas Mulier at tmulier@bloomberg.net


American Apparel's Future
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

Companies Mentioned

  • ILMN
    (Illumina Inc)
    • $176.64 USD
    • 2.65
    • 1.5%
Market data is delayed at least 15 minutes.
 
blog comments powered by Disqus